Rayaldee is now approved! Visit the new Rayaldee Web Site  

Promoting Health through Vitamin D Therapeutics

Improving People's Lives by Treating and Preventing the Clinical Consequences of
Vitamin D Insufficiency and Secondary Hyperparathyroidism


Recent News:

New Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023
November 02, 2023

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023
October 25, 2023

RAYALDEE® Launched in Germany by OPKO Health’s Licensee, VFMCRP
February 3, 2022




© 2023 OPKO Health Inc.- All rights reserved. | Privacy Policy | Terms Of Use